The goal of this thesis is to present the evidence for the role of NMDA receptor excitotoxicity in pathology of Alzheimer's disease, epilepsy, major depressive disorder and ischemic stroke, evaluate the neuroprotective effects of NMDA receptor antagonists ketamine and memantine based on excitotoxicity research, and review the current body of evidence on their potential use as a treatment for these conditions. Keywords: excitotoxicity, ketamine, memantine, NMDAR, neurodegeneration
The paper reviews clinical trials evaluating the efficacy of N-methyl-D-aspartate (NMDA) receptor an...
Excitotoxicity is considered to be an important mechanism involved in various neurodegenerative dise...
The NMDAR glutamate receptor subtype mediates various vital physiological neuronal functions. Howeve...
Pharmacological inhibition of NMDA receptor activity by ketamine is accompanied by pyschotomimetic s...
The pathogenesis of stroke, trauma and chronic degenerative diseases, such as Alzheimer s disease (A...
Alzheimer's disease (AD) is a neurodegenerative disorder characterized by the presence in the brain ...
NMDA receptors have been widely reported to be involved in the regulation of synaptic plasticity thr...
Alzheimer’s disease (AD) is a progressive neurodegenerative disease that causes problems with ...
Glutamatergic system is the main excitatory system and glutamatergic receptors are the most abundant...
Excitotoxicity is thought to be a major mechanism in many human disease states such as ischemia, tra...
NMDA receptors (NMDARs), a subfamily of ionotropic glutamate receptors, have unique biophysical prop...
Ketamine is used as an anaesthetic mainly in veterinary medicine and paediatrics. Thirteen years ago...
Memantine is an uncompetitive antagonist with moderate affinity for NMDA receptors, and it demonstra...
NMDA (N-methyl-D-aspartate) receptors are glutamate-gated ion channels, which are located in the cen...
Glutamate is the major excitatory neurotransmitter in the mammalian central nervous system and its e...
The paper reviews clinical trials evaluating the efficacy of N-methyl-D-aspartate (NMDA) receptor an...
Excitotoxicity is considered to be an important mechanism involved in various neurodegenerative dise...
The NMDAR glutamate receptor subtype mediates various vital physiological neuronal functions. Howeve...
Pharmacological inhibition of NMDA receptor activity by ketamine is accompanied by pyschotomimetic s...
The pathogenesis of stroke, trauma and chronic degenerative diseases, such as Alzheimer s disease (A...
Alzheimer's disease (AD) is a neurodegenerative disorder characterized by the presence in the brain ...
NMDA receptors have been widely reported to be involved in the regulation of synaptic plasticity thr...
Alzheimer’s disease (AD) is a progressive neurodegenerative disease that causes problems with ...
Glutamatergic system is the main excitatory system and glutamatergic receptors are the most abundant...
Excitotoxicity is thought to be a major mechanism in many human disease states such as ischemia, tra...
NMDA receptors (NMDARs), a subfamily of ionotropic glutamate receptors, have unique biophysical prop...
Ketamine is used as an anaesthetic mainly in veterinary medicine and paediatrics. Thirteen years ago...
Memantine is an uncompetitive antagonist with moderate affinity for NMDA receptors, and it demonstra...
NMDA (N-methyl-D-aspartate) receptors are glutamate-gated ion channels, which are located in the cen...
Glutamate is the major excitatory neurotransmitter in the mammalian central nervous system and its e...
The paper reviews clinical trials evaluating the efficacy of N-methyl-D-aspartate (NMDA) receptor an...
Excitotoxicity is considered to be an important mechanism involved in various neurodegenerative dise...
The NMDAR glutamate receptor subtype mediates various vital physiological neuronal functions. Howeve...